Kresko RNAtech
PrivateLast Round
Accelerator
May 1, 2026
Total Funding Raised
$825,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kresko RNAtech operates in Healthcare & Life Sciences and is based in Buenos Aires. Its latest recorded funding round was an Accelerator round in July 2025.
Kresko RNAtech is a biotechnology company that produces next-generation nutritional ingredients by identifying and stabilizing bioactive RNAs from natural sources.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kresko RNAtech Comparables
Compare Kresko RNAtech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuritas | 78% | |
| Brightseed | 78% | |
| Geltor | 72% |
For institutional investors. Book with your work email.
Kresko RNAtech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 1, 2026 | ||||
| Accelerator | Jul 15, 2025 | ||||
| Accelerator | Jul 1, 2023 | ||||
| Accelerator | May 25, 2023 | ||||
| Pre Seed | Jan 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kresko RNAtech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Parallel18 | Accelerator |
| Foodland Ventures | Accelerator |
| GRIDX | Pre Seed |
| IndieBio | Accelerator |
| MassChallenge Israel | Accelerator |
| SOSV | Accelerator |
| National Innovation Agency (Public Organization) | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 103% MoM, from 78 to 158.
- May 1, 2026
Secured funding from Foodland Ventures and Mahidol University.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 19, 2026
Kresko RNATech and EHU advance a collaboration to evaluate bioactive RNAs in ex vivo human intestinal biopsies.
- attends_eventOct 19, 2026
Kresko RNATech presents at SPACE-F Demo Day in Bangkok, Thailand.
- partners_withOct 19, 2026
On Oct 19th '26, Kresko RNATech partners with MIT group in United States to expand its scientific network through collaboration with MIT researchers.
For institutional investors. Book with your work email.
Kresko RNAtech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kresko RNAtech's valuation, stock price, and market status.
Is Kresko RNAtech a public or private company?
Kresko RNAtech is a private company.
What is the current stock price of Kresko RNAtech?
Kresko RNAtech is a private company, so its shares have no public market price. Caplight tracks Kresko RNAtech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kresko RNAtech worth (valuation)?
Valuation information for Kresko RNAtech is not publicly available.
Can I buy Kresko RNAtech stock?
Kresko RNAtech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kresko RNAtech's last funding round?
Kresko RNAtech's most recent funding round was Accelerator on May 1, 2026.
Who are the main investors in Kresko RNAtech?
Key investors in Kresko RNAtech include GRIDX, SOSV.
Will Kresko RNAtech IPO soon?
No public IPO plans have been announced for Kresko RNAtech.
How can I track Kresko RNAtech secondary market activity?
Caplight tracks bids, offers, and trades in Kresko RNAtech's shares on secondary markets.